111 related articles for article (PubMed ID: 2940581)
21. [Treatment of leishmaniasis (author's transl)].
Barabe P
Med Trop (Mars); 1981; 41(6):599-605. PubMed ID: 7339417
[TBL] [Abstract][Full Text] [Related]
22. Pseudo-acute transformation of an idiopathic myelofibrosis due to kala-azar.
Disdier P; Swiader L; Serratrice J; Mary C; Weiller PJ
Br J Haematol; 1998 Feb; 100(2):449. PubMed ID: 9488642
[No Abstract] [Full Text] [Related]
23. [Clinico-epidemiological study of kala-azar in the south of Madrid].
de la Serna FJ; Salto E; Valdés D; Vos Saus R
Rev Sanid Hig Publica (Madr); 1987; 61(7-8):783-98. PubMed ID: 3438697
[No Abstract] [Full Text] [Related]
24. [Two cases of kala-azar treated with glucantime].
MATOS J; VELASCO JA
Acta Pediatr Esp; 1955 Nov; 13(155):959-63. PubMed ID: 13301754
[No Abstract] [Full Text] [Related]
25. A case report of Kala-Azar in a kidney transplant patient.
Malek Hosseini SA; Javid R; Salahi H; Nezakatgoo N; Ahmad E; Ghahramani N
Transplant Proc; 1995 Oct; 27(5):2715. PubMed ID: 7482886
[No Abstract] [Full Text] [Related]
26. The chemotherapy of protozoal infections: whither?
Steck EA
J Protozool; 1981 Feb; 28(1):30-5. PubMed ID: 6265632
[No Abstract] [Full Text] [Related]
27. [Kala-azar. Presentation of 7 cases and review of the literature].
García de Miguel MJ; López-Herce Cid J; Ramirez Balza O; Vidal López ML; García Hortelano J
An Esp Pediatr; 1984 Oct; 21(6):587-92. PubMed ID: 6395745
[TBL] [Abstract][Full Text] [Related]
28. [Diagnosis and treatment of kala-azar].
Neves J
Rev Paul Med; 1983; 101(6):237-9. PubMed ID: 6677985
[No Abstract] [Full Text] [Related]
29. Meglumine antimoniate-induced pancreatitis.
Torrús D; Massa B; Boix V; Portilla J; Pérez-Mateo M
Am J Gastroenterol; 1996 Apr; 91(4):820-1. PubMed ID: 8677970
[No Abstract] [Full Text] [Related]
30. [Association of acute lymphoblastic leukaemia and visceral leishmaniasis].
Nafil H; Tazi I; Mahmal L
Ann Biol Clin (Paris); 2011; 69(6):729-31. PubMed ID: 22123576
[TBL] [Abstract][Full Text] [Related]
31. Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.
Singh RP; Picado A; Alam S; Hasker E; Singh SP; Ostyn B; Chappuis F; Sundar S; Boelaert M
Trop Med Int Health; 2012 Nov; 17(11):1345-8. PubMed ID: 22882665
[TBL] [Abstract][Full Text] [Related]
32. [Kala-azar in infants].
Fournier A; Henninot E; Ducoulombier H; Cousin J; Duhamel M
J Sci Med Lille; 1971 Mar; 89(3):115-20. PubMed ID: 5126293
[No Abstract] [Full Text] [Related]
33. Visceral leishmaniasis and disseminated intravascular coagulation in a dog.
Font A; Gines C; Closa JM; Mascort J
J Am Vet Med Assoc; 1994 Apr; 204(7):1043-4. PubMed ID: 8045804
[TBL] [Abstract][Full Text] [Related]
34. [Kala-azar in Pernambuco. Report of 2 new cases].
Huggins D
An Inst Hig Med Trop (Lisb); 1973; 1(1-4):17-23. PubMed ID: 4805664
[No Abstract] [Full Text] [Related]
35. Mediterranean visceral leishmaniasis in pregnancy.
Gradoni L; Gaeta GB; Pellizzer G; Maisto A; Scalone A
Scand J Infect Dis; 1994; 26(5):627-9. PubMed ID: 7855563
[TBL] [Abstract][Full Text] [Related]
36. [Adult Mediterranean visceral leishmaniasis: report of 12 cases (author's transl)].
Sebahoun G; Imbert C; Sainty D; Carcassonne Y
Ann Med Interne (Paris); 1980; 131(2):75-7. PubMed ID: 7396324
[TBL] [Abstract][Full Text] [Related]
37. Cytogenetic observations after meglumine antimoniate therapy for visceral leishmaniasis.
Hantson P; Léonard ED; Crutzen-Fayt MC; Léonard A; Vandercam B; Delaere B; Mahieu P
Pharmacotherapy; 1996; 16(5):869-71. PubMed ID: 8888081
[TBL] [Abstract][Full Text] [Related]
38. [Kala-azar and autoimmune hemolytic anemia. Apropos of a fatally developing case caused by hepatotoxicity from N-methylglucamine antimonate].
De Pablos Gallego JM; Cabrera Torres A; Almagro M; De Puerta S; López Garrido P; Gómez Morales M; Esquivias JJ
Rev Clin Esp; 1982 Mar; 164(6):417-20. PubMed ID: 7111811
[No Abstract] [Full Text] [Related]
39. Post-kala-azar dermal leishmaniasis (PKDL) developing after treatment of visceral leishmaniasis with amphotericin B and miltefosine.
Kumar D; Ramesh V; Verma S; Ramam M; Salotra P
Ann Trop Med Parasitol; 2009 Dec; 103(8):727-30. PubMed ID: 20030997
[No Abstract] [Full Text] [Related]
40. Treatment of paediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds?
Kafetzis DA; Velissariou IM; Stabouli S; Mavrikou M; Delis D; Liapi G
Int J Antimicrob Agents; 2005 Jan; 25(1):26-30. PubMed ID: 15620822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
